For the three classical complement activator proteins C1q, C1r and C1s, strong evidence for altered levels is lacking, with a trend for increased levels in AD plasma in C1q and C1r (39, 53) while no differences are reported related to C1s (54). This evidence concerns the gene C1R and Alzheimer disease.